Washington Health Center COVID-19 Survey Summary Report

Latest data from January 14, 2022

Number of Health Center respondents = 21 (78% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, Antigen)1 19,297
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, Antigen) 61.18%
Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen)1 7,149
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, Antigen) 65.64%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, Antigen)2 Patients Tested Positive, Virus Detection (PCR, Antigen)2
White, Non-Hispanic/Latino Patients 33.43% 29.92%
White, Hispanic/Latino Patients 22.59% 24.55%
Black/African American, Non-Hispanic/Latino Patients 3.58% 4.43%
Black/African American, Hispanic/Latino Patients 0.24% 0.22%
Asian Patients3 4.24% 4.11%
American Indian/Alaska Native Patients3 3.31% 3.09%
Native Hawaiian/Other Pacific Islander Patients3 1.45% 1.55%
Patients with More Than One Race3 6.89% 7.71%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 10.40% 11.48%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 2.15% 2.52%
Unreported/Refused to Report Race and Ethnicity 11.73% 10.41%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 5,990
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 64.67%
COVID-19 Immunization Series Completed 7,041
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 64.24%
COVID-19 Immunization Series Additional 14,216
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 55.07%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 30.18% 31.19% 39.39%
White, Hispanic/Latino Patients 23.72% 20.12% 17.07%
Black/African American, Non-Hispanic/Latino Patients 4.42% 4.93% 3.17%
Black/African American, Hispanic/Latino Patients 0.17% 0.16% 0.13%
Asian Patients3 7.28% 10.45% 13.56%
American Indian/Alaska Native Patients3 1.54% 1.28% 1.66%
Native Hawaiian/Other Pacific Islander Patients3 1.79% 1.51% 0.81%
Patients with More Than One Race3 8.46% 7.81% 7.39%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 7.86% 9.77% 4.51%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 3.51% 4.10% 3.25%
Unreported/Refused to Report Race and Ethnicity 11.07% 8.68% 9.07%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, Antigen)

Metrics Value
Less Than 1 Hour 9.52%
1 to 24 Hours 14.29%
More Than 24 Hours 71.43%
N/A 4.76%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 9.52%
Staffing to administer the vaccine 47.62%
Vaccine confidence 52.38%
Vaccine storage capacity 4.76%
Vaccine supply 14.29%
Other 4.76%
None 19.05%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 9.52%
Average Percent of Health Center Visits Conducted Virtually 17.38%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 23.81%
Number of Mobile Van Sites 2
Number of Pop-up Clinics 20
Number of School-Based Vaccination Sites 8
Number of Family Vaccination Clinics 3

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 4.76%
Refer patients to another organization that provides monoclonal antibody therapies 42.86%
None 52.38%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 9.52%
Patient awareness/education 9.52%
Staffing capacity 33.33%
Therapy administration/onsite logistics 19.05%
Other 9.52%
None 47.62%

Test Kit Distribution

Metrics Value
Number of Health Centers that Distributed Test Kits Received through the HRSA COVID-19 Testing Supply Program 9
Number of Test Kits Distributed through the HRSA COVID-19 Testing Supply Program 85,702

Test Kit Distribution Methods4

Metrics Value
Provide to Existing Health Center Patients 88.89%
Provide to General Public Who Came to the Health Center 44.44%
Provide at Special Vaccination Events (e.g., through mobile vans, pop-up clinics, school-based clinics, family vaccination clinics) 22.22%
Provide at Other Community Events 33.33%
Provide through direct outreach to specific populations (i.e., individuals experiencing homelessness, MSAWs, residents of public housing, individuals with limited English proficiency) 44.44%
Other 55.56%

Oral Antiviral Medication Distribution

Metrics Value
Number of Health Centers that Provided COVID-19 Oral Antiviral Medication through the HRSA Health Center COVID-19 Therapeutics Program 3
Racial and/or Ethnic Minority Patients Who Received COVID-19 Oral Antiviral Medication5 31.25%

Oral Antiviral Medication Distribution by Race and Ethnicity5

Race/Ethnicity Value
White, Non-Hispanic/Latino Patients 56.25%
White, Hispanic/Latino Patients 6.25%
Black/African American, Non-Hispanic/Latino Patients 0.00%
Black/African American, Hispanic/Latino Patients 0.00%
Asian Patients3 12.50%
American Indian/Alaska Native Patients3 6.25%
Native Hawaiian/Other Pacific Islander Patients3 0.00%
Patients with More Than One Race3 0.00%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 6.25%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to Report Race) 6.25%
Unreported/Refused to Report Race and Ethnicity 0.00%

Oral Antiviral Medication Distribution by Special/Vulnerable Population5

Metrics Value
Migratory/Agricultural Workers 31.25%
Patients Experiencing Homelessness 0.00%
Patients Who Are Residents of Public Housing 0.00%
Patients with Limited English Proficiency 25.00%
Children Under 18 Years of Age 0.00%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

4 Percentages are calculated using the number of health centers that have distributed test kits received through the HRSA COVID-19 Testing Supply Program as the denominator.

5 Percentages are calculated using the number of health centers that have distributed courses of COVID-19 oral antiviral medication received through the HRSA Health Center COVID-19 Therapeutics Program as the denominator.

Date Last Reviewed:  January 2022